Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35939675)
Watch
English
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
title
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells
(English)
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
author
Michela Spadaro
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Alessandra Lugaresi
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Antonio Bertolotto
series ordinal
5
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
author name string
Marzia Caldano
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Fabiana Marnetto
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
publication date
12 August 2015
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
published in
Journal of Neuroinflammation
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
volume
12
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
page(s)
146
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
exact match
https://scigraph.springernature.com/pub.10.1186/s12974-015-0365-x
0 references
cites work
Current management of relapsing-remitting multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Multiple sclerosis: current knowledge and future outlook
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Risk of natalizumab-associated progressive multifocal leukoencephalopathy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell death
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
2 October 2017
Progressive multifocal leukoencephalopathy. A cause of visual loss.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
11 July 2018
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
24 September 2018
FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532246
retrieved
24 September 2018
Effects of natalizumab on circulating B cells, T regulatory cells and natural killer cells
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26259673
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26259673
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Effects of cryopreservation with polyethylene glycol on the expression of CD11b and CD62L on the surface of polymorphonuclear leukocytes
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/26259673
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1186/S12974-015-0365-X
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Dimensions Publication ID
1052755680
0 references
PMCID
4532246
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
PubMed ID
26259673
1 reference
stated in
Europe PubMed Central
PMCID
4532246
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26259673%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
ResearchGate publication ID
280968380
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
